Navigation Links
Halozyme to Host Second Quarter 2013 Financial Results Conference Call
Date:7/31/2013

SAN DIEGO, July 31, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2013 on Wednesday, August 7, 2013 at 4:30 p.m. ET/1:30 p.m. PT. Gregory I. Frost, President and Chief Executive Officer, will lead the call. On the same date post-market, Halozyme will release financial results for the second quarter 2013.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The call will be webcast live through the "Investors" section of Halozyme's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to www.halozyme.com approximately fifteen minutes prior to the call to register, download, and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (877) 407-8037 (domestic callers) or (201) 689-8037 (international callers). A telephone replay will be available shortly after the call by dialing (877) 660-6853 (domestic callers) or (201) 612-7415 (international callers) using replay ID number 418819.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Investor Contact:
David Ramsay
Halozyme Therapeutics
858-704-8260
ir@halozyme.com

Media Contact:
Nurha Hindi
Hill + Knowlton Strategies
818-522-8411
Nurha.Hindi@hkstrategies.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
2. Halozyme Reports First Quarter 2012 Financial Results
3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
6. Halozyme Reports Second Quarter 2012 Financial Results
7. Halozyme to Host Third Quarter Financial Results Conference Call
8. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
10. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 08, 2019 , ... Clements Ferry Dentistry has rebranded ... team are thrilled to create an atmosphere that is even more inviting and ... The mission of Sedation Dentistry of Charleston is to provide trusted, comprehensive dental ...
(Date:10/8/2019)... Vicksburg, MS (PRWEB) , ... October 08, 2019 ... ... Dentistry, recently participated in an advanced dental implant seminar to enhance his skill ... around the country, The Implant Dentistry Continuum™ is a four-part series of classes ...
(Date:10/8/2019)... ... October 08, 2019 , ... For many Americans, dental insurance ... procedures is paid out of pocket. Yearly insurance payouts are generally capped at around ... including 46 million people who are 65 or older. (Standard Medicare does not cover ...
Breaking Medicine Technology:
(Date:10/17/2019)... ... October 17, 2019 , ... A clinical article reviewing the long-term performance of ... Award at Plastic Surgery - The Meeting 2019 in San Diego last month. The ... authored by Larry S. Nichter, M.D., Robert A. Hardesty, M.D., and Gregg M. Anigian, ...
(Date:10/15/2019)... ... ... In 2019, Unitek opened its doors to various nursing students from Brightwood ... who started in July were only entering their second term when the school closed ... start over. Then the leadership team at Unitek honored their commitment to the community ...
(Date:10/11/2019)... ... October 11, 2019 , ... A Topping Out event was hosted today ... general contractors Adolfson & Peterson Construction. The event celebrated reaching the final height of ... in Dallas. The first of its kind in Texas, STA’s facility will be home ...
(Date:10/8/2019)... ... October 08, 2019 , ... Safe Harvest soups ... Meyer, King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , Safe Harvest reinvented classic ... , “Ingredient purity and fresh taste is paramount for us,” says Bryan Boches, ...
(Date:10/8/2019)... ... October 08, 2019 , ... Cognosante ... the Department of Veterans Affairs Community Care Referrals and Authorizations program. The new ... VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community care ...
Breaking Medicine News(10 mins):